Table 5.

Kidney, lung and plasma antioxidant and oxidation product data of the rats (GSH: reduced glutathione, GSHPx: glutathione peroxidase, CD: conjugated dienes, CT: conjugated trienes, MDA: malondialdehyde).

Kidney	Days in Treatment	Control	20 ppm	50 ppm	100 ppm
GSH (micromol/g)	5	2.65 ± 0.44 a	4.26 ± 1.09 ab	6.65 ± 0.79 ab	5.24 ± 1.00 b
	10	3.19 ± 0.47 a	4.68 ± 0.21 b	4.86 ± 0.46 b	5.3 ± 0.61 b
GSHPx (IU/g prot.)	5	2.47 ± 0.38 ab	1.99 ± 0.86 a	3.13 ± 0.4 b	2.5 ± 0.33 ab
	10	2.11 ± 0.1 a	2.89 ± 0.35 b	2.82 ± 0.18 b	2.97 ± 0.51 b
MDA (nmol/g)	5	52.2 ± 8.0 ab	57.7 ± 5.09 b	44.3 ± 2.89 a	63.4 ± 10.1 b
	10	66.5 ± 11.3 b	55.0 ± 8.27 ab	41.9 ± 6.24 a	54.8 ± 9.75 ab
Lung	Days in Treatment	Control	20 ppm	50 ppm	100 ppm
GSH (micromol/g)	5	3.44 ± 0.39	3.81 ± 0.54	3.4 ± 0.37	3.41 ± 0.33
	10	3.49 ± 0.45	3.75 ± 0.47	2.94 ± 0.44	3.26 ± 0.58
GSHPx (IU/g prot.)	5	2.97 ± 0.42	3.26 ± 0.68	3.16 ± 0.48	3.06 ± 0.36
	10	2.69 ± 0.29	2.97 ± 0.63	2.56 ± 0.27	2.67 ± 0.48
MDA (nmol/g)	5	28.6 ± 6.54 ab	35.2 ± 6.67 b	24.1 ± 3.16 a	27.7 ± 4.28 ab
	10	35.3 ± 4.91 a	55.6 ± 5.03 c	39.1 ± 2.78 ab	42.9 ± 4.25 b
Plasma	Days in Treatment	Control	20 ppm	50 ppm	100 ppm
GSH (micromol/g)	5	3.34 ± 0.29 ab	3.44 ± 0.34 b	2.8 ± 0.34 a	3.45 ± 0.38 b
	10	3.16 ± 0.25 a	3.46 ± 0.29 ab	3.32 ± 0.23 ab	3.97 ± 0.83 b
GSHPx (IU/g prot.)	5	3.02 ± 0.35 b	2.47 ± 0.17 a	2.47 ± 0.36 a	2.57 ± 0.33 ab
	10	2.69 ± 0.25	2.73 ± 0.19	2.83 ± 0.29	2.58 ± 0.34
MDA (nmol/g)	5	12.4 ± 1.43 a	14.1 ± 1.46 ab	14.5 ± 1.3 ab	15.3 ± 1.24 b
	10	12.4 ± 0.91 a	14.5 ± 1.63 b	12.4 ± 0.6 a	16.7 ± 1.11 c

^{a, b}: small uppercase letters indicate significant difference (p < 0.05) between means of one row. Bold number pairs indicate significant difference (p < 0.05) between 5- and 10-day treatment data.